NeuroMetrix Inc (NURO)
4.31
-0.02
(-0.46%)
USD |
NASDAQ |
Apr 25, 12:56
NeuroMetrix Enterprise Value: -9.396M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | -9.396M |
April 23, 2024 | -9.179M |
April 22, 2024 | -8.919M |
April 19, 2024 | -9.396M |
April 18, 2024 | -10.75M |
April 17, 2024 | -10.91M |
April 16, 2024 | -11.02M |
April 15, 2024 | -11.00M |
April 12, 2024 | -10.59M |
April 11, 2024 | -10.35M |
April 10, 2024 | -10.67M |
April 09, 2024 | -10.45M |
April 08, 2024 | -10.45M |
April 05, 2024 | -10.39M |
April 04, 2024 | -10.24M |
April 03, 2024 | -10.35M |
April 02, 2024 | -10.13M |
April 01, 2024 | -9.932M |
March 28, 2024 | -9.554M |
March 27, 2024 | -9.733M |
March 26, 2024 | -10.05M |
March 25, 2024 | -9.892M |
March 22, 2024 | -9.753M |
March 21, 2024 | -9.912M |
March 20, 2024 | -10.31M |
Date | Value |
---|---|
March 19, 2024 | -10.19M |
March 18, 2024 | -10.33M |
March 15, 2024 | -10.37M |
March 14, 2024 | -10.43M |
March 13, 2024 | -10.21M |
March 12, 2024 | -10.23M |
March 11, 2024 | -10.25M |
March 08, 2024 | -10.15M |
March 07, 2024 | -10.09M |
March 06, 2024 | -10.05M |
March 05, 2024 | -10.61M |
March 04, 2024 | -10.49M |
March 01, 2024 | -10.01M |
February 29, 2024 | -9.932M |
February 28, 2024 | -11.49M |
February 27, 2024 | -12.37M |
February 26, 2024 | -12.75M |
February 23, 2024 | -13.25M |
February 22, 2024 | -13.51M |
February 21, 2024 | -13.16M |
February 20, 2024 | -12.66M |
February 16, 2024 | -12.80M |
February 15, 2024 | -12.93M |
February 14, 2024 | -13.38M |
February 13, 2024 | -13.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.42M
Minimum
Sep 27 2023
130.84M
Maximum
Jul 22 2021
2.422M
Average
0.7048M
Median
Aug 23 2022
Enterprise Value Benchmarks
Teleflex Inc | 11.53B |
Perspective Therapeutics Inc | 984.38M |
Xtant Medical Holdings Inc | 131.97M |
Asensus Surgical Inc | 45.03M |
Catheter Precision Inc | 0.9737M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.650M |
Revenue (Quarterly) | 1.318M |
Total Expenses (Quarterly) | 3.175M |
EPS Diluted (Quarterly) | -1.082 |
Gross Profit Margin (Quarterly) | 64.35% |
Profit Margin (Quarterly) | -125.2% |
Earnings Yield | -136.5% |
Normalized Earnings Yield | -136.47 |